Musacchio, Lucia
Califano, Daniela
Bartoletti, Michele http://orcid.org/0000-0002-9631-5693
Arenare, Laura
Lorusso, Domenica
Losito, Nunzia Simona
Cormio, Gennaro
Greggi, Stefano
Raspagliesi, Francesco
Valabrega, Giorgio
Salutari, Vanda
Pisano, Carmela
Spina, Anna
Russo, Daniela
Del Sesto, Michele
Canzonieri, Vincenzo
FerraĆ¹, Francesco
Zannoni, Gian Franco
Loizzi, Vera
Ghizzoni, Viola
Casanova, Claudia
Tuninetti, Valentina
Ducceschi, Monika
Del Vecchio, Vittoria
Scalone, Simona
Priolo, Domenico
Perrone, Francesco
Scambia, Giovanni
Pignata, Sandro http://orcid.org/0000-0002-8836-2633
Article History
Received: 9 February 2022
Revised: 7 June 2022
Accepted: 13 June 2022
First Online: 22 July 2022
Competing interests
: DL reports research funding from Clovis, GSK and MSD, personal interests with AstraZeneca, Clovis Oncology, GSK, Pharmamar, MSD and financial interests with Clovis, Genmab, GSK, MSD. Board of Directors, GCIG (Gynecologic Cancer Inter Group). FR reports honoraria from GSK, Pharmamar, Clovis, MSD and Roche. VS reports honoraria from GSK, PharmaMar, Roche, MSD, EISAI, Clovis, Oncology, AstraZeneca. FP reports honoraria for educational and advisory activity from Incyte, GSK, Eli Lilly, Ipsen, Astellas, AstraZeneca, Roche, BMS, Bayer, Clovis, Pierre Fabre and grants for clinical trials to his institution from Roche, Astra Zeneca, Pfizer, MSD, Bayer, Incyte Taiho, Janssen, Exelixis, Ailenor, Daiichi Sankyo. GS reports research support from MSD and honoraria from Clovis Oncology. Consultant for Tesaro and Johnson & Johnson. SP reports honoraria from AstraZeneca, MSD, Roche, Pfizer, Clovis, GSK, Pharmamar and research funding from MSD, Roche, Astrazeneca and Pfizer. LM, DC, MB, LA, NSL, GC, SG, GV, CP, AS, DR, MDS, VC, FF, GFZ, VL, VG, CC, VT, MD, VDV, SS and DP have nothing to disclose.
: This study was approved by the ethics committee of the National Cancer Institute of Naples (22/14 OSS) and the ethics committees of the participating centers, and it was conducted in accordance with the Declaration of Helsinki. The study participants gave written informed consent.